1. Aim
The aim of the Clinical Product Evaluation committee is to
ensure the hospital evaluates and selects medical devices that
are:
For further information regarding the evaluation and selection
of medical devices for the RCH, refer to the Clinical
Products Advisory homepage.
2. Accountability
The Clinical Product Evaluation committee reports to the
Clinical Leadership Team via the Executive Director, Nursing
Services..
3. Responsibilities
To manage the entry of medical devices into the Royal
Children's Hospital to ensure safety, efficacy and quality and
standards are met.
To manage and facilitate both major and minor procurements and
subsequent, evaluations to ensure the most appropriate medical
device is purchased in the most cost effective manner.
To have clear guidelines for introducing new medical
devices
To draft policies and guidelines for the introduction of new
medical devices.
To develop and implement an assessment tool for the evaluation
of medical devices
Ensure evaluation committees are aware of probity and
procurement responsibilities.
Identification of risk and the management of the risk
4. Committee Membership
Material Resources Manager
Chief Biomedical Engineer
Clinical Products Advisor
Others may be invited to meetings as required
5. Meeting Times
The Clinical Product Evaluation committee will meet as
required
6. Chair
The chairperson will be the Clinical Products Advisor, or in
their absence, the Biomedical Engineering Manager.
7. Minutes
Minutes are to be recorded for each meeting, are to be
distributed to all committee members and are to be tabled at the
next scheduled meeting.
8. Review
Terms of Reference will be reviewed at least once per
annum.